Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,769 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined hepatocellular cholangiocarcinoma: Controversies to be addressed.
Wang AQ, Zheng YC, Du J, Zhu CP, Huang HC, Wang SS, Wu LC, Wan XS, Zhang HH, Miao RY, Sang XT, Zhao HT. Wang AQ, et al. Among authors: wang ss. World J Gastroenterol. 2016 May 14;22(18):4459-65. doi: 10.3748/wjg.v22.i18.4459. World J Gastroenterol. 2016. PMID: 27182157 Free PMC article. Review.
CMTTdb: the cancer molecular targeted therapy database.
Bai X, Yang X, Wu L, Zuo B, Lin J, Wang S, Bian J, Sang X, He Y, Yang Z, Zhao H. Bai X, et al. Ann Transl Med. 2019 Nov;7(22):667. doi: 10.21037/atm.2019.10.23. Ann Transl Med. 2019. PMID: 31930068 Free PMC article.
Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study.
Zhu C, Li H, Yang X, Wang S, Wang Y, Zhang N, Wang Y, Xue J, Zhang L, Ning C, Yang X, Xun Z, Chao J, Long J, Sang X, Zhu Z, Zhao H. Zhu C, et al. Cancer Immunol Immunother. 2023 Sep;72(9):2949-2960. doi: 10.1007/s00262-023-03466-8. Epub 2023 May 29. Cancer Immunol Immunother. 2023. PMID: 37247023 Free PMC article.
2,769 results